TMED T. Rowe Price Health Care ETF

ETF on NASDAQ (US) · Actively managed · Listing

Form N-PORT Jun 30, 2026 vs Mar 31, 2026 Filed with the SEC Aug 27, 2026
Book +13% $20.3M → $23.0M
Line items (Mar 31, 2026: 109) 102
In top 10 48%
Largest holding: Eli Lilly and Company ($3.85M) 16.7%
Portfolio date Jun 30, 2026
New / increased 24 / 27
Reduced / closed 44 / 30
Unchanged 6
−100%

Most notable sale · Abbott Laboratories

Abbott Laboratories sold out

Shares went from 7,720 to 0 ($793K → $0). Was 3.9% of the Mar 31, 2026 portfolio.

11x

Most notable buy · Intuitive Surgical, Inc.

Intuitive Surgical, Inc. raised 11x

Shares went from 134 to 1,410 ($61.8K → $561K). Now 2.4% of the portfolio. Estimated trade $507K.

Largest holding: Eli Lilly and Company, raised 1%, 3,209 shares ($3.85M).

Eli Lilly and Company: 16.7% UnitedHealth Group Incorporated: 6.5% Gilead Sciences, Inc.: 4.4% Thermo Fisher Scientific Inc: 4.1% Danaher Corporation: 3.0% Cencora, Inc.: 2.8% Agilent Technologies, Inc.: 2.6% Alnylam Pharmaceuticals, Inc.: 2.6% Intuitive Surgical, Inc.: 2.4% Insulet Corporation: 2.4% The other 92 positions: 52.5% $23.0M Holdings value
Current positions Top 10 % of book
Eli Lilly and Company LLY $3.85M · +1% sh 16.7%
UnitedHealth Group Incorporated UNH $1.50M · −26% sh 6.5%
Gilead Sciences, Inc. GILD $1.02M · +34% sh 4.4%
Thermo Fisher Scientific Inc TMO $948K · −<1% sh 4.1%
Danaher Corporation DHR $682K · +23% sh 3.0%
Cencora, Inc. COR $634K · 3.3x sh 2.8%
Agilent Technologies, Inc. A $602K · +51% sh 2.6%
Alnylam Pharmaceuticals, Inc. ALNY $598K · +57% sh 2.6%
Intuitive Surgical, Inc. ISRG $561K · 11x sh 2.4%
Insulet Corporation PODD $548K · 4.5x sh 2.4%

Slices are % of holdings value. Changes ("sh" shares, "units" other holdings) are in the quantity held against Mar 31, 2026.

Healthcare: 98.0% Technology: 1.0% Unclassified: 1.0% 2 sectors
Sectors % of holdings value
Healthcare 98.0%
Technology 1.0%
Unclassified 1.0%
Biotechnology: 37.8% Drug Manufacturers - General: 20.6% Medical Instruments & Supplies: 11.2% Medical Devices: 11.0% Healthcare Plans: 10.7% Medical Distribution: 4.2% Medical Care Facilities: 1.5% Other (2): 2.0% Unclassified: 1.0% 9 industries
Industries % of holdings value
Biotechnology 37.8%
Drug Manufacturers - General 20.6%
Medical Instruments & Supplies 11.2%
Medical Devices 11.0%
Healthcare Plans 10.7%
Medical Distribution 4.2%
Medical Care Facilities 1.5%
Other (2) 2.0%
Unclassified 1.0%
Initiations 24 Value
Pfizer, Inc. PFE 1.9% of portfolio $439K
Ascendis Pharma A/S ASND 1.6% of portfolio $369K
McKesson Corporation MCK 1.5% of portfolio $335K
HCA Healthcare, Inc. HCA 1.0% of portfolio $219K
Elevance Health, Inc. ELV 0.8% of portfolio $176K
Tenet Healthcare Corporation THC 0.6% of portfolio $130K
Alignment Healthcare, Inc. ALHC 0.5% of portfolio $115K
Revvity, Inc. RVTY 0.4% of portfolio $103K
Beone Medicines Ltd. ONC 0.4% of portfolio $91.8K
Akeso, Inc. 9926 0.4% of portfolio $90.1K
4D Molecular Therapeutics, Inc. FDMT 0.3% of portfolio $73.7K
Oruka Therapeutics, Inc. ORKA 0.3% of portfolio $71.0K
Increases 27 Change
Intuitive Surgical, Inc. ISRG $61.8K → $561K 11x
Cencora, Inc. COR $215K → $634K 3.3x
Insulet Corporation PODD $169K → $548K 4.5x
Gilead Sciences, Inc. GILD $839K → $1.02M +34%
Alnylam Pharmaceuticals, Inc. ALNY $418K → $598K +57%
Agilent Technologies, Inc. A $341K → $602K +51%
Denali Therapeutics Inc. DNLI $98.2K → $282K 2.1x
IDEXX Laboratories, Inc. IDXX $149K → $271K +94%
BioNTech SE BNTX $163K → $297K +74%
Danaher Corporation DHR $553K → $682K +23%
Stryker Corporation SYK $406K → $511K +31%
DexCom, Inc. DXCM $204K → $335K +53%
Reductions 44 Change
UnitedHealth Group Incorporated UNH $1.33M → $1.50M −26%
Humana Inc. HUM $318K → $286K −61%
Becton, Dickinson and Company BDX $346K → $166K −50%
Adaptive Biotechnologies Corporation ADPT $168K → $96.1K −63%
Molina Healthcare Inc MOH $144K → $95.1K −62%
Rapport Therapeutics, Inc. RAPP $106K → $47.0K −67%
Erasca, Inc. ERAS $103K → $26.7K −77%
Xenon Pharmaceuticals Inc. XENE $149K → $73.4K −52%
Kymera Therapeutics, Inc. KYMR $125K → $109K −37%
Waters Corporation WAT $355K → $388K −13%
NovoCure Limited NVCR $93.7K → $72.2K −45%
Amylyx Pharmaceuticals, Inc. AMLX $79.4K → $46.9K −54%
Terminations 30 Change
Abbott Laboratories ABT was $793K −100%
Medtronic plc. MDT was $454K −100%
Boston Scientific Corporation BSX was $298K −100%
ASCENDIS PHARMA A/S - ADR was $282K −100%
APELLIS PHARMACEUTICALS INC was $208K −100%
Regeneron Pharmaceuticals, Inc. REGN was $206K −100%
Bristol-Myers Squibb Company BMY was $148K −100%
Agios Pharmaceuticals, Inc. AGIO was $132K −100%
Novo Nordisk A/S NVO was $118K −100%
Align Technology, Inc. ALGN was $109K −100%
Alkermes plc ALKS was $108K −100%
Natera, Inc. NTRA was $101K −100%

The other 12 initiations

OnKure Therapeutics, Inc. ($69.9K), Sartorius Aktiengesellschaft ($68.7K), Kardigan, Inc. ($64.3K), Maze Therapeutics, Inc. ($49.4K), Allogene Therapeutics, Inc. ($48.2K), Oric Pharmaceuticals, Inc. ($47.4K), Spyre Therapeutics, Inc. ($46.6K), Damora Therapeutics Inc ($46.5K), Avalyn Pharma Inc. ($41.0K), Abivax SA ($27.9K), CENTESSA PHARMACEUTICALS-ADR CVR ($0), CONTRA APELLIS PHARMAC COMMON STOCK ($0)

The other 18 terminations

Guardant Health, Inc. ($85.8K), CENTESSA PHARMACEUTICALS-ADR ($79.0K), Edwards Lifesciences Corporation ($77.8K), Immunocore Holdings plc ($74.4K), ICON plc ($67.7K), Travere Therapeutics, Inc. ($58.9K), Relay Therapeutics, Inc. ($51.8K), YPSOMED HOLDING AG-REG ($49.8K), Oscar Health, Inc. ($45.9K), Charles River Laboratories International, Inc. ($43.5K), Bruker Corporation ($43.2K), Bio-Techne Corp ($31.0K), Olema Oncology, Inc. ($29.8K), SOLENO THERAPEUTICS INC ($26.1K), Janux Therapeutics, Inc. ($20.2K), Tango Therapeutics, Inc. ($19.5K), BillionToOne, Inc. ($18.0K), Revolution Medicines, Inc. ($9.24K)

Source: the fund's quarterly portfolio reports to the SEC, the portfolio of Jun 30, 2026 (Form N-PORT) vs the portfolio of Mar 31, 2026 (Form N-PORT). Percent changes are changes in the quantity held (shares, or units for holdings that are not a listed equity); dollar values are as reported at each period end. Each column is ranked by the estimated dollar size of the trade: a new or closed position at its value, otherwise the change in shares at the position's own period-end price. Where shares and price per share moved by inverse whole multiples (a split), the earlier share count is restated. Cash and money-market lines are in the book and its value but are never counted as trades. Short positions are listed as such, at their (negative) printed value.

Objective

The fund seeks long-term capital appreciation.

Principal investment strategies

The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of health care companies. The fund defines health care companies as companies engaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciences tools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities. The fund references the MSCI GICS (Global Industry Classification Standard) Health Care sector to identify such companies. Any derivatives that provide exposure to the investment focus suggested by the fund's name, or to one or more market risk factors associated with the investment focus suggested by the fund's name, are counted (as applicable) toward compliance with the fund's 80% investment policy. T. ROWE PRICE 2 As a fundamental policy, the fund will concentrate (invest more than 25% of its net assets) in health care companies. The majority of the fund will be invested in equity securities, such as common stocks. While most assets are typically invested in U.S. common stocks, the fund may invest in foreign stocks in keeping with its objective. The fund uses fundamental, bottom-up analysis and may invest in companies of any market capitalization. The adviser may use both growth and value approaches in selecting investments for the fund. The fund is nondiversified, which means it may invest a greater percentage of its assets in a particular issuer than is permissible for a diversified fund.

Management and Contact

Adviser
T. Rowe Price Associates, Inc.
Sub-adviser
T. Rowe Price Investment Management, Inc.
Portfolio managers

Sal Rais (Portfolio Manager and Chair of Investment Advisory Committee, since 2025, 2021)

Phone
1-800-638-5660

Holdings as of Jun 30, 2026

102 lines, 93 linked, weights sum to 100.00% · Actively managed (N-CEN)

Holding Ticker / identifier Type Shares Change Weight Market value
ELI LILLY & CO US5324571083 Equity 3,209 +20 16.71% $ 3.849M
UNITEDHEALTH GROUP INC US91324P1021 Equity 3,614 −1,284 6.52% $ 1.502M
GILEAD SCIENCES INC US3755581036 Equity 8,084 +2,064 4.44% $ 1.021M
THERMO FISHER SCIENTIFIC INC US8835561023 Equity 1,890 −3 4.11% $ 947.57K
DANAHER CORP US2358511028 Equity 3,580 +662 2.96% $ 681.918K
CENCORA INC US03073E1055 Equity 2,240 +1,555 2.75% $ 633.875K
AGILENT TECHNOLOGIES INC US00846U1016 Equity 4,530 +1,534 2.61% $ 601.72K
ALNYLAM PHARMACEUTICALS INC US02043Q1076 Equity 1,986 +724 2.60% $ 597.846K
INTUITIVE SURGICAL INC US46120E6023 Equity 1,410 +1,276 2.43% $ 560.729K
INSULET CORP US45784P1012 Equity 3,601 +2,798 2.38% $ 548.252K
STRYKER CORP US8636671013 Equity 1,624 +389 2.22% $ 511.3K
DYNE THERAPEUTICS INC US26818M1080 Equity 21,069 +100 2.03% $ 467.942K
ELANCO ANIMAL HEALTH INC US28414H1032 Equity 17,864 +4,436 1.91% $ 439.633K
PFIZER INC US7170811035 Equity 18,228 new +18,228 1.91% $ 438.93K
CYTOKINETICS INC US23282W6057 Equity 4,564 −158 1.69% $ 388.807K
WATERS CORP US9418481035 Equity 1,034 −158 1.68% $ 387.791K
WEST PHARMACEUTICAL SERVICES US9553061055 Equity 1,060 −138 1.65% $ 380.54K
ASCENDIS PHARMA A/S DK0060615755 Equity 1,382 new +1,382 1.60% $ 368.607K
BIOGEN INC US09062X1037 Equity 1,654 +264 1.55% $ 357.363K
MCKESSON CORP US58155Q1031 Equity 444 new +444 1.46% $ 335.486K
DEXCOM INC US2521311074 Equity 4,976 +1,725 1.46% $ 335.134K
IMMUNOME INC US45257U1088 Equity 15,009 +4,340 1.38% $ 318.041K
BIONTECH SE-ADR US09075V1026 Equity 3,188 +1,359 1.29% $ 296.643K
HUMANA INC US4448591028 Equity 721 −1,114 1.24% $ 286.396K
DENALI THERAPEUTICS INC US24823R1059 Equity 10,962 +5,846 1.22% $ 281.943K
CVS HEALTH CORP US1266501006 Equity 2,717 +19 1.22% $ 281.074K
IDEXX LABORATORIES INC US45168D1046 Equity 515 +249 1.18% $ 271.117K
VAXCYTE INC US92243G1085 Equity 4,655 +519 1.18% $ 270.595K
METTLER-TOLEDO INTERNATIONAL US5926881054 Equity 174 −4 0.97% $ 222.287K
HCA HEALTHCARE INC US40412C1018 Equity 562 new +562 0.95% $ 219.118K
IMMATICS NV NL0015285941 Equity 19,722 +3,354 0.87% $ 199.784K
REPLIGEN CORP US7599161095 Equity 1,430 +71 0.85% $ 195.109K
ELEVANCE HEALTH INC US0367521038 Equity 456 new +456 0.77% $ 176.349K
SHATTUCK LABS INC US82024L1035 Equity 25,348 +1,237 0.76% $ 175.915K
APOGEE THERAPEUTICS INC US03770N1019 Equity 1,309 −349 0.75% $ 173.744K
STATE STREET INS US GO MM FD-IS
US8574927062 Money market 169,172.27 +142,163.98 0.73% $ 169.172K
BECTON DICKINSON AND CO US0758871091 Equity 1,098 −1,104 0.72% $ 166.16K
MOONLAKE IMMUNOTHERAPEUTICS KY61559X1045 Equity 7,823 −1,896 0.66% $ 152.314K
COOPER COS INC/THE US2166485019 Equity 2,088 −109 0.65% $ 149.73K
CABALETTA BIO INC US12674W1099 Equity 45,659 +2,029 0.62% $ 141.999K
CG ONCOLOGY INC US1569441009 Equity 1,996 −32 0.62% $ 141.816K
TENET HEALTHCARE CORP US88033G4073 Equity 693 new +693 0.56% $ 129.646K
BICARA THERAPEUTICS INC US0554771032 Equity 4,103 −4,207 0.53% $ 121.818K
ALIGNMENT HEALTHCARE INC US01625V1044 Equity 4,840 new +4,840 0.50% $ 115.24K
SAREPTA THERAPEUTICS INC US8036071004 Equity 6,068 −749 0.47% $ 109.042K
KYMERA THERAPEUTICS INC US5015751044 Equity 949 −548 0.47% $ 108.822K
REVVITY INC US7140461093 Equity 926 new +926 0.45% $ 103.027K
ADAPTIVE BIOTECHNOLOGIES US00650F1093 Equity 4,479 −7,605 0.42% $ 96.075K
MOLINA HEALTHCARE INC US60855R1005 Equity 416 −666 0.41% $ 95.139K
BEONE MEDICINES LTD-ADR US07725L1026 Equity 322 new +322 0.40% $ 91.76K
MAPLIGHT THERAPEUTICS INC US56565P1030 Equity 2,543 −2,567 0.40% $ 91.141K
AKESO INC KYG0146B1032 Equity 8,000 new +8,000 0.39% $ 90.078K
KODIAK SCIENCES INC US50015M1099 Equity 2,147 −558 0.36% $ 83.647K
GENEDX HOLDINGS CORP US81663L2007 Equity 1,200 +309 0.36% $ 82.38K
DIANTHUS THERAPEUTICS INC US2528281080 Equity 816 −32 0.35% $ 79.544K
AVALO THERAPEUTICS INC US05338F3064 Equity 4,287 −2,627 0.34% $ 79.224K
INCYTE CORP US45337C1027 Equity 669 −729 0.33% $ 75.838K
4D MOLECULAR THERAPEUTICS IN US35104E1001 Equity 5,545 new +5,545 0.32% $ 73.749K
XENON PHARMACEUTICALS INC CA98420N1050 Equity 1,216 −1,342 0.32% $ 73.398K
NOVOCURE LTD JE00BYSS4X48 Equity 4,764 −3,834 0.31% $ 72.175K
EIKON THERAPEUTICS INC US2825641036 Equity 5,522 −318 0.31% $ 72.062K
ORUKA THERAPEUTICS INC US6876041087 Equity 746 new +746 0.31% $ 70.997K
STOKE THERAPEUTICS INC US86150R1077 Equity 2,167 −301 0.31% $ 70.904K
ONKURE THERAPEUTICS INC US68277Q1058 Equity 15,335 new +15,335 0.30% $ 69.928K
STEVANATO GROUP SPA IT0005452658 Equity 3,869 −2,640 0.30% $ 69.913K
SARTORIUS AG DE0007165607 Equity 320 new +320 0.30% $ 68.734K
CARIS LIFE SCIENCES INC US1421521071 Equity 3,694 +317 0.29% $ 65.827K
KARDIGAN INC US4859251013 Equity 2,695 new +2,695 0.28% $ 64.276K
CRINETICS PHARMACEUTICALS IN US22663K1079 Equity 1,596 −162 0.26% $ 59.722K
GRAIL INC US3847471014 Equity 868 −536 0.26% $ 59.258K
ARCUS BIOSCIENCES INC US03969F1093 Equity 1,868 −1,965 0.25% $ 57.59K
MAZE THERAPEUTICS INC US5787841007 Equity 1,656 new +1,656 0.21% $ 49.415K
AKTIS ONCOLOGY INC US01021M1045 Equity 1,517 −1,204 0.21% $ 48.893K
ALLOGENE THERAPEUTICS INC US0197701065 Equity 23,151 new +23,151 0.21% $ 48.154K
ORIC PHARMACEUTICALS INC US68622P1093 Equity 4,380 new +4,380 0.21% $ 47.435K
RAPPORT THERAPEUTICS INC US75383L1026 Equity 1,127 −2,265 0.20% $ 46.962K
AMYLYX PHARMACEUTICALS INC US03237H1014 Equity 2,611 −3,100 0.20% $ 46.894K
Spyre Therapeutics Inc US00773J2024 Equity 525 new +525 0.20% $ 46.61K
Damora Therapeutics Inc
US36322Q2066 Equity 1,788 new +1,788 0.20% $ 46.506K
ENLIVEN THERAPEUTICS INC US29337E1029 Equity 891 −244 0.20% $ 45.218K
PROCEPT BIOROBOTICS CORP US74276L1052 Equity 1,951 +501 0.19% $ 44.054K
DISC MEDICINE INC US2546041011 Equity 600 −241 0.19% $ 43.884K
AVALYN PHARMA INC US05348Y1055 Equity 1,244 new +1,244 0.18% $ 40.952K
IONIS PHARMACEUTICALS INC US4622221004 Equity 509 −341 0.18% $ 40.359K
SCHRODINGER INC US80810D1037 Equity 2,236 +574 0.16% $ 36.335K
BLACK DIAMOND THERAPEUTICS I US09203E1055 Equity 15,259 −284 0.12% $ 28.229K
ABIVAX SA-ADR US00370M1036 Equity 209 new +209 0.12% $ 27.851K
ERASCA INC US29479A1088 Equity 1,460 −4,888 0.12% $ 26.747K
PERSONALIS INC US71535D1063 Equity 1,990 −1,990 0.12% $ 26.666K
KARYOPHARM THERAPEUTICS INC US48576U2050 Equity 2,470 −2,014 0.10% $ 24.132K
PRIME MEDICINE INC US74168J1016 Equity 6,152 −12,299 0.10% $ 22.701K
IMMUNOVANT INC US45258J1025 Equity 580 −168 0.10% $ 22.347K
BIOHAVEN LTD VGG1110E1079 Equity 1,458 −3,165 0.09% $ 21.695K
CRISPR THERAPEUTICS AG CH0334081137 Equity 381 −328 0.09% $ 20.78K
KARYOPHARM WTS 10.28 TC4ZZLSW8
Equity 3,159 0 0.08% $ 17.514K
ANNEXON INC US03589W1027 Equity 2,087 −7,228 0.05% $ 11.917K
JASPER THERA WTS 3/30 TC8U3IZJ8
Equity 5,370 0 0.01% $ 1,524.01
CONTRA 89BIO INC COMMON STOCK
US282CVR0187 Equity 2,477 0 0.00% $ 0.00
CENTESSA PHARMACEUTICALS-ADR CVR
152CVR015 Equity 1,490 new +1,490 0.00% $ 0.00
CONTRA APELLIS PHARMAC COMMON STOCK
US037CVR0169 Equity 499 new +499 0.00% $ 0.00
APPLIED THERAPEUTICS INC CVR
APLT 038CVR031 Equity 153,622 0 0.00% $ 0.00
METSERA INC CVR
MTSR 592CVR013 Equity 1,892 0 0.00% $ 0.00

Trades Mar 31, 2026 to Jun 30, 2026

Holding Ticker Action Before After Change Value
ABBOTT LABORATORIES Closed 7,720 — −7,720 $ -792.612K
UNITEDHEALTH GROUP INC Sold 4,898 3,614 −1,284 $ -533.669K
INTUITIVE SURGICAL INC Bought 134 1,410 +1,276 $ 507.44K
MEDTRONIC PLC Closed 5,245 — −5,245 $ -454.479K
HUMANA INC Sold 1,835 721 −1,114 $ -442.503K
CENCORA INC Bought 685 2,240 +1,555 $ 440.034K
PFIZER INC New — 18,228 +18,228 $ 438.93K
INSULET CORP Bought 803 3,601 +2,798 $ 425.996K
ASCENDIS PHARMA A/S New — 1,382 +1,382 $ 368.607K
MCKESSON CORP New — 444 +444 $ 335.486K
BOSTON SCIENTIFIC CORP Closed 4,745 — −4,745 $ -297.749K
ASCENDIS PHARMA A/S - ADR
Closed 1,235 — −1,235 $ -282.482K
GILEAD SCIENCES INC Bought 6,020 8,084 +2,064 $ 260.766K
HCA HEALTHCARE INC New — 562 +562 $ 219.118K
ALNYLAM PHARMACEUTICALS INC Bought 1,262 1,986 +724 $ 217.946K
APELLIS PHARMACEUTICALS INC
Closed 5,162 — −5,162 $ -207.667K
REGENERON PHARMACEUTICALS Closed 267 — −267 $ -206.295K
AGILENT TECHNOLOGIES INC Bought 2,996 4,530 +1,534 $ 203.761K
ELEVANCE HEALTH INC New — 456 +456 $ 176.349K
BECTON DICKINSON AND CO Sold 2,202 1,098 −1,104 $ -167.068K
ADAPTIVE BIOTECHNOLOGIES Sold 12,084 4,479 −7,605 $ -163.127K
MOLINA HEALTHCARE INC Sold 1,082 416 −666 $ -152.314K
DENALI THERAPEUTICS INC Bought 5,116 10,962 +5,846 $ 150.359K
BRISTOL-MYERS SQUIBB CO Closed 2,432 — −2,432 $ -147.501K
AGIOS PHARMACEUTICALS INC Closed 3,906 — −3,906 $ -132.14K
IDEXX LABORATORIES INC Bought 266 515 +249 $ 131.084K
TENET HEALTHCARE CORP New — 693 +693 $ 129.646K
BIONTECH SE-ADR Bought 1,829 3,188 +1,359 $ 126.455K
DANAHER CORP Bought 2,918 3,580 +662 $ 126.098K
BICARA THERAPEUTICS INC Sold 8,310 4,103 −4,207 $ -124.906K
STRYKER CORP Bought 1,235 1,624 +389 $ 122.473K
NOVO-NORDISK A/S-SPONS ADR Closed 3,200 — −3,200 $ -117.6K
DEXCOM INC Bought 3,251 4,976 +1,725 $ 116.179K
ALIGNMENT HEALTHCARE INC New — 4,840 +4,840 $ 115.24K
ELANCO ANIMAL HEALTH INC Bought 13,428 17,864 +4,436 $ 109.17K
ALIGN TECHNOLOGY INC Closed 634 — −634 $ -108.687K
ALKERMES PLC Closed 3,048 — −3,048 $ -107.777K
REVVITY INC New — 926 +926 $ 103.027K
NATERA INC Closed 504 — −504 $ -100.795K
RAPPORT THERAPEUTICS INC Sold 3,392 1,127 −2,265 $ -94.383K
MAPLIGHT THERAPEUTICS INC Sold 5,110 2,543 −2,567 $ -92.001K
IMMUNOME INC Bought 10,669 15,009 +4,340 $ 91.965K
BEONE MEDICINES LTD-ADR New — 322 +322 $ 91.76K
AKESO INC New — 8,000 +8,000 $ 90.078K
ERASCA INC Sold 6,348 1,460 −4,888 $ -89.548K
GUARDANT HEALTH INC Closed 929 — −929 $ -85.812K
INCYTE CORP Sold 1,398 669 −729 $ -82.639K
XENON PHARMACEUTICALS INC Sold 2,558 1,216 −1,342 $ -81.003K
CENTESSA PHARMACEUTICALS-ADR
Closed 1,990 — −1,990 $ -79.043K
EDWARDS LIFESCIENCES CORP Closed 971 — −971 $ -77.758K
IMMUNOCORE HOLDINGS PLC-ADR Closed 2,468 — −2,468 $ -74.41K
4D MOLECULAR THERAPEUTICS IN New — 5,545 +5,545 $ 73.749K
ORUKA THERAPEUTICS INC New — 746 +746 $ 70.997K
ONKURE THERAPEUTICS INC New — 15,335 +15,335 $ 69.928K
SARTORIUS AG New — 320 +320 $ 68.734K
ICON PLC Closed 612 — −612 $ -67.724K
KARDIGAN INC New — 2,695 +2,695 $ 64.276K
KYMERA THERAPEUTICS INC Sold 1,497 949 −548 $ -62.839K
ARCUS BIOSCIENCES INC Sold 3,833 1,868 −1,965 $ -60.581K
WATERS CORP Sold 1,192 1,034 −158 $ -59.256K
TRAVERE THERAPEUTICS INC Closed 1,982 — −1,982 $ -58.885K
NOVOCURE LTD Sold 8,598 4,764 −3,834 $ -58.085K
BIOGEN INC Bought 1,390 1,654 +264 $ 57.04K
AMYLYX PHARMACEUTICALS INC Sold 5,711 2,611 −3,100 $ -55.676K
RELAY THERAPEUTICS INC Closed 5,205 — −5,205 $ -51.79K
YPSOMED HOLDING AG-REG
Closed 142 — −142 $ -49.78K
WEST PHARMACEUTICAL SERVICES Sold 1,198 1,060 −138 $ -49.542K
MAZE THERAPEUTICS INC New — 1,656 +1,656 $ 49.415K
AVALO THERAPEUTICS INC Sold 6,914 4,287 −2,627 $ -48.547K
ALLOGENE THERAPEUTICS INC New — 23,151 +23,151 $ 48.154K
STEVANATO GROUP SPA Sold 6,509 3,869 −2,640 $ -47.705K
ORIC PHARMACEUTICALS INC New — 4,380 +4,380 $ 47.435K
BIOHAVEN LTD Sold 4,623 1,458 −3,165 $ -47.095K
Spyre Therapeutics Inc New — 525 +525 $ 46.61K
Damora Therapeutics Inc
New — 1,788 +1,788 $ 46.506K
APOGEE THERAPEUTICS INC Sold 1,658 1,309 −349 $ -46.323K
OSCAR HEALTH INC - CLASS A Closed 3,999 — −3,999 $ -45.869K
PRIME MEDICINE INC Sold 18,451 6,152 −12,299 $ -45.383K
CHARLES RIVER LABORATORIES Closed 252 — −252 $ -43.47K
BRUKER CORP Closed 1,196 — −1,196 $ -43.2K
ANNEXON INC Sold 9,315 2,087 −7,228 $ -41.272K
AVALYN PHARMA INC New — 1,244 +1,244 $ 40.952K
AKTIS ONCOLOGY INC Sold 2,721 1,517 −1,204 $ -38.805K
MOONLAKE IMMUNOTHERAPEUTICS Sold 9,719 7,823 −1,896 $ -36.915K
GRAIL INC Sold 1,404 868 −536 $ -36.593K
IMMATICS NV Bought 16,368 19,722 +3,354 $ 33.976K
BIO-TECHNE CORP Closed 593 — −593 $ -30.99K
VAXCYTE INC Bought 4,136 4,655 +519 $ 30.169K
OLEMA PHARMACEUTICALS INC Closed 1,997 — −1,997 $ -29.775K
ABIVAX SA-ADR New — 209 +209 $ 27.851K
IONIS PHARMACEUTICALS INC Sold 850 509 −341 $ -27.038K
PERSONALIS INC Sold 3,980 1,990 −1,990 $ -26.666K
SOLENO THERAPEUTICS INC
Closed 780 — −780 $ -26.114K
ELI LILLY & CO Bought 3,189 3,209 +20 $ 23.989K
KODIAK SCIENCES INC Sold 2,705 2,147 −558 $ -21.74K
GENEDX HOLDINGS CORP Bought 891 1,200 +309 $ 21.213K
JANUX THERAPEUTICS INC Closed 1,455 — −1,455 $ -20.225K
KARYOPHARM THERAPEUTICS INC Sold 4,484 2,470 −2,014 $ -19.677K
TANGO THERAPEUTICS INC Closed 933 — −933 $ -19.518K
BILLIONTOONE INC CL A Closed 228 — −228 $ -17.998K
CRISPR THERAPEUTICS AG Sold 709 381 −328 $ -17.889K
DISC MEDICINE INC Sold 841 600 −241 $ -17.627K
CYTOKINETICS INC Sold 4,722 4,564 −158 $ -13.46K
SAREPTA THERAPEUTICS INC Sold 6,817 6,068 −749 $ -13.46K
ENLIVEN THERAPEUTICS INC Sold 1,135 891 −244 $ -12.383K
PROCEPT BIOROBOTICS CORP Bought 1,450 1,951 +501 $ 11.313K
STOKE THERAPEUTICS INC Sold 2,468 2,167 −301 $ -9,848.72
REPLIGEN CORP Bought 1,359 1,430 +71 $ 9,687.24
SCHRODINGER INC Bought 1,662 2,236 +574 $ 9,327.50
REVOLUTION MEDICINES INC Closed 95 — −95 $ -9,238.75
SHATTUCK LABS INC Bought 24,111 25,348 +1,237 $ 8,584.78
COOPER COS INC/THE Sold 2,197 2,088 −109 $ -7,816.39
IMMUNOVANT INC Sold 748 580 −168 $ -6,473.04
CABALETTA BIO INC Bought 43,630 45,659 +2,029 $ 6,310.19
CRINETICS PHARMACEUTICALS IN Sold 1,758 1,596 −162 $ -6,062.04
CARIS LIFE SCIENCES INC Bought 3,377 3,694 +317 $ 5,648.94
METTLER-TOLEDO INTERNATIONAL Sold 178 174 −4 $ -5,110.04
EIKON THERAPEUTICS INC Sold 5,840 5,522 −318 $ -4,149.90
DIANTHUS THERAPEUTICS INC Sold 848 816 −32 $ -3,119.36
CG ONCOLOGY INC Sold 2,028 1,996 −32 $ -2,273.60
DYNE THERAPEUTICS INC Bought 20,969 21,069 +100 $ 2,221.00
CVS HEALTH CORP Bought 2,698 2,717 +19 $ 1,965.55
THERMO FISHER SCIENTIFIC INC Sold 1,893 1,890 −3 $ -1,504.08
BLACK DIAMOND THERAPEUTICS I Sold 15,543 15,259 −284 $ -525.40
CENTESSA PHARMACEUTICALS-ADR CVR
New — 1,490 +1,490 $ 0.00
CONTRA APELLIS PHARMAC COMMON STOCK
New — 499 +499 $ 0.00

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up